Which co-infections accelerate HIV disease progression and increase mortality?

AIIMS CRE 2025

Medical Surgical Nursing

Medium

Appeared in: AIIMS CRE 2025

Explanation

Hepatitis B (HBV) and Hepatitis C (HCV) share common transmission routes with HIV, such as blood, sexual contact, and vertical transmission, leading to high rates of co-infection.
HIV co-infection significantly accelerates the natural history of chronic HBV and HCV, leading to a higher risk of cirrhosis, end-stage liver disease, and hepatocellular carcinoma (liver cancer).
In the era of effective antiretroviral therapy (ART), chronic liver disease resulting from HBV or HCV co-infection has become a major cause of non-AIDS-related morbidity and mortality in people with HIV.
Studies show a significantly increased risk of death due to liver disease in patients chronically infected with both HIV and HCV/HBV compared to those with either infection alone.

Option A: Malaria and Dengue are acute, vector-borne (mosquito) diseases. They do not establish chronic infection or share the same synergistic pathway of accelerating liver disease and mortality in HIV patients as hepatitis viruses do.
Option C: Cholera and Typhoid are acute bacterial infections transmitted via the fecal-oral route (contaminated food/water). They cause gastrointestinal illness and are not chronic viral co-factors that accelerate HIV progression.
Option D: Influenza and Measles are acute respiratory viruses. While they can cause more severe illness in people with HIV due to immunosuppression, they do not cause chronic liver disease or have the same long-term impact on HIV disease progression and mortality as chronic hepatitis.

Visual 1: Venn Diagram - Illustrating the overlapping transmission routes (blood, sexual contact, vertical transmission) for HIV, Hepatitis B, and Hepatitis C.
Visual 2: Infographic - Comparing the disease progression timeline of chronic hepatitis in a person with and without HIV co-infection, showing accelerated progression to cirrhosis and liver cancer in the co-infected individual.

Clinical Relevance

Nursing practice connection: Knowing Impact of Co-infections on HIV Progression helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
Routine screening for HBV and HCV is a standard of care for all newly diagnosed HIV patients, as management strategies for HIV and hepatitis are interconnected.
Nurses must be vigilant in monitoring liver function tests (LFTs) in co-infected patients, as some antiretroviral drugs can be hepatotoxic, and flares of hepatitis can occur upon starting ART (immune reconstitution).
Patient education is critical, focusing on medication adherence, alcohol avoidance to protect the liver, and safe practices to prevent transmission to others.

How to Approach the Question

First, identify the core of the question: it asks for co-infections that not only occur with HIV but specifically accelerate its progression and increase mortality in a chronic, synergistic way.
Consider the transmission routes of HIV (bloodborne, sexual, vertical). Co-infections with similar transmission routes are likely to be common.
Evaluate each option based on its nature: Is it a chronic or acute infection? Is it viral, bacterial, or parasitic? How is it transmitted?
Eliminate options involving acute infections (Cholera, Influenza) or those with different primary transmission vectors (Malaria, Dengue), as they are less likely to have the long-term synergistic effect described.
Recognize that Hepatitis B and C are chronic viral infections that primarily affect the liver and share transmission routes with HIV. This makes them strong candidates for causing long-term, compounded health issues.
Recall or deduce that the combined assault on the immune system (from HIV) and the liver (from hepatitis) leads to faster disease progression and is a major cause of death in this population.

Concept Tested & Keywords

Qr6sib1ygjiCiAmFOgaEj5